The transcriptional programs that specify the distinct components of the cardiac conduction system are poorly understood, in part due to a paucity of definitive molecular markers. In the present study we show that a cGATA-6 gene enhancer can be used to selectively express transgenes in the atrioventricular (AV) conduction system as it becomes manifest in the developing multichambered mouse heart. Furthermore, our analysis of staged cGATA-6/lacZ embryos revealed that the activity of this heart-region-specific enhancer can be traced back essentially to the outset of the cardiogenic program. We provide evidence that this enhancer reads medial/lateral and anterior/posterior positional information before the heart tube forms and we show that the activity of this enhancer becomes restricted at the heart looping stage to AV myocardial cells that induce endocardial cushion formation. We infer that a deeply-rooted heart-region-specific transcriptional program serves to coordinate AV valve placement and AV conduction system formation. Lastly, we show that cGATA-6/Cre mice can be used to delete floxed genes in the respective subsets of specialized heart cells. q
Introduction
The genetic programs that regulate the early stages of heart development are well conserved among vertebrates and are similar to those that govern the formation of invertebrate heart-like organs such as the Drosophila dorsal vessel (reviewed in Chien, 2000; Fishman and Chien, 1997; Mohun and Sparrow, 1997; Olson and Srivastava, 1996; Srivastava and Olson, 2000) . Briefly, mesodermal cells in bilaterally symmetrical anterior lateral regions of vertebrate embryos become committed to a cardiogenic fate during gastrulation in response to endodermally-derived signals. These two heart forming regions expand in an anterior medial direction and coalesce over the anterior intestinal portal to form a crescent of cardiogenic cells. The linear heart tube emerges as an anterior extension of this cardiac crescent.
In vertebrates, the linear heart tube further matures into a complex multichambered organ. The atrioventricular (AV) canal, which lies between the developing atrial and ventricular chambers, is the site of two critical restructuring events of relevance to the present study. First, myocardial cells on opposite sides of the AV canal induce subjacent endocardial cells to form the major endocardial cushions which septate the canal and contribute to the formation of the tricuspid and mitral valves (Mjaatvedt et al., 1999; Wessels et al., 1996) . In contrast, atrial and ventricular myocardial cells that flank the AV canal lack this inductive property (Runyan and Markwald, 1983) . Second, as detailed below, a subset of myocardial cells in the right margin of the AV canal become incorporated into a component of the conduction system . It remains to be determined how these critical morphogenetic events are governed at the transcriptional level.
Three conduction system components can be distinguished in the vertebrate heart based on their anatomical locations, electrophysiological properties, histological characteristics and gene expression patterns (reviewed in Moorman and Lamers, 1999) . The first component, the sinoatrial node (which is also known as the pacemaker) initiates www.elsevier.com/locate/modo cardiac depolarization. This depolarization initially causes the atria to contract. The depolarization wave then converges in the proximal component of the atrioventricular conduction system (AVCS). In the fully septated heart the proximal AVCS is the only myocardial connection between atria and ventricles, and is comprised of the AV node and AV (or His) bundle. The AVCS delays the cardiac impulse across the AV canal, causing the atrial and ventricular chambers to beat sequentially rather than simultaneously. The third component, the ventricular conduction system, consists of the left and right bundle branches and the fine network of Purkinje cells which promote the fast conduction of the cardiac impulse so that the large ventricular chambers contract in a concerted manner.
The origin of cardiac conduction system cells was debated for many years. In the case of the ventricular conduction system, direct evidence of a myocardial cell origin was recently provided by following the fate of chick embryo cells infected in ovo with a replication defective retroviral vector (Gourdie et al., 1995) . These authors further showed that cultured myocardial cells from early stage chick embryos can be induced to express Purkinje cell markers in response to endothelin, which is secreted by coronary arteries in situ (Gourdie et al., 1998) . Whereas Purkinje cells normally arise in proximity to coronary arteries in the chick heart, no such spatial relationship has been reported for the mouse or human heart.
The parameters that regulate the formation of the other two components of the conduction system (i.e. the sinoatrial node and AVCS) have not been determined for any organism. However, two lines of evidence suggest that AVCS cells derive from immature AV canal myocardial cells. First, the molecular phenotype of the mature AVCS is similar to that of the immature AV canal myocardium (reviewed in Moorman and Lamers, 1999) . Second, AVCS cells can be preferentially marked by infecting early stage chick embryos with replication-defective episomal adenoviral vectors. Immature AV canal myocardial cells are among the first heart cells to become post-mitotic (Cheng et al., 1999) and, hence, episomes in these cells are not diluted by further cell division.
Much remains to be learned about the transcriptional events that govern the regional specification of myocardial cells and, in particular, the myocardial cells that become incorporated into various components of the cardiac conduction system. Recent studies indicate that myocardial cells are assigned anterior/posterior (A/P) positional information early in the cardiogenic program, prior to linear heart tube formation (Yutzey and Bader, 1995) . Cardiac myocytes are also patterned with respect to the dorsal/ ventral axis of the linear heart (Christoffels et al., 2000) which becomes the inner/outer curvature axis of the looped heart. In contrast, as yet there has been no evidence that medial/lateral (M/L) patterning occurs until after the heart looping stage, when TGF-b2, BMP2 and several other genes are preferentially expressed on the top and bottom quadrants of the AV canal (i.e. between the inner and outer curvatures) in myocardial cells that induce subjacent endocardial cells to initiate endocardial cushion formation (Nakajima et al., 2000; Romano and Runyan, 2000) . Whereas a few transgenes are differentially expressed along the A/P axis prior to heart tube formation (Ross et al., 1996; Xavier-Neto et al., 1999) , none are differentially regulated along the left/right (L/R), dorsal/ventral (D/V) or M/L axes of the developing heart. Note that the right and left ventricles are initially positioned along, and hence patterned with respect to, the A/P axis rather than the L/R axis.
The evolutionarily conserved GATA-6 transcription factor is an early marker of the cardiogenic lineage in vertebrate species (Jiang and Evans, 1996; Jiang et al., 1998; Koutsourakis et al., 1999; Laverriere et al., 1994; Morrisey et al., 1996) . We previously identified two qualitatively distinct heart-specific enhancers upstream of the chicken GATA-6 (cGATA-6) gene that serve as valuable 'cardiosensors' (Kelly et al., 1999) in transgenic mice (Davis et al., 2000; He and Burch, 1997) . The present report highlights novel transgenic properties of one of these enhancers. In particular, we show that this enhancer is selectively activated in a subset of early cardiogenic cells and that, as development proceeds, it sequentially marks immature AV canal myocardial cells and both immature and mature AVCS cells. This enhancer thus provides a unique means to decipher the transcriptional codes that govern these stage specific facets of heart morphogenesis. This enhancer also provides a way to selectively express genes of interest in myocardial cells that induce formation of the AV septum and AV valves (at the heart looping stage) and in myocardial derived cells that comprise a component of the conduction system (in the multichambered heart). As a case in point, we used this enhancer to express the Cre recombinase gene. These GATA-6/Cre transgenic mice can be used to selectively delete floxed genes in the respective subsets of specialized heart cells and, in addition, provide a means to follow the fates of cells that transiently activate this enhancer but fail to become incorporated into the AV conduction system.
Results
2.1. A cGATA-6 gene heart-region-specific enhancer marks the AVCS in transgenic mouse embryos
We previously reported that a [21.5/10.8]cGATA-6/lacZ construct was expressed in myocardium on two sides of the AV canal in looped hearts of (embryonic day (E)9.5-10) transient transgenic mouse embryos (He and Burch, 1997) . To move toward a more comprehensive analysis of the expression pattern dictated by this 2.3 kb cGATA-6 gene fragment, we made three lines of [21.5/10.8]cGATA-6/ lacZ mice and confirmed that this transgene is expressed in the AV canal at E9.5-10 as expected (for example, see Fig.  1A ). To test whether the cGATA-6 promoter and flanking Fig. 1 . A cGATA-6 gene enhancer directs heart-region-specific expression in transgenic mouse embryos at E9.5-10. Three lines of transgenic mice were made for both of the cGATA-6/lacZ constructs depicted at the top of this figure. The expression pattern for a [21.5/10.8]cGATA-6/lacZ line (A) is virtually identical to the patterns for two [21.5/10 .0]cGATA-6/lacZ lines (B,C). Frontal and sagittal sections through the hearts of representative transgenic embryos are shown in (D) and (E), respectively. Note that expression is primarily restricted to AV canal myocardial cells that lie over the developing AV endocardial cushions whereas no expression is seen over the OT cushions. A three-dimensional reconstruction of the AV canal region of an E10 heart is shown in (F-H). Note that the atrial and ventricular myocardium are depicted by yellow and red wire mesh, respectively, whereas the endocardial cushions are shown as solid purple and green. The two bands of lacZ-positive cells are highlighted in blue. AT, atrium; ec, endocardial cushion; OT, outflow tract; VE, ventricle. sequence are sufficient to account for this expression pattern, we also made a related construct that lacks the cGATA-6 first intron. Test matings with mice from three transgenic lines revealed that this [21.5/10.0]GATA-6/lacZ construct is also expressed in the AV canal at E9.5-10 (for example, see Fig. 1B ,C). Frontal and sagittal sections through two [21.5/10.0]GATA-6/lacZ embryos confirmed that transgene expression is primarily restricted to the myocardial cells that overlie the developing endocardial cushions, although some atrial cells are also lacZ positive at this stage (Fig. 1D,E) . This restricted expression is even more clearly demonstrated in the three dimensional reconstruction of the AV canal region of the E10 heart shown in Fig. 1F-H . Fig. 1F shows cGATA-6/lacZ expression (blue) relative to the inferior AV cushion (solid purple), superior AV cushion (solid green), ventricular myocardium (red wire frame), and atrial myocardium (yellow wire frame). In Fig. 1G the atrial and ventricular myocardium are removed, and in Fig. 1H the AV cushions are also removed to highlight the lacZ-positive cells on either side of the AV canal.
We set up additional matings to assay this cGATA-6 gene enhancer at earlier stages: namely, at E7.5 (soon after cells become committed to a cardiogenic fate); at E7.5-8 (the cardiac crescent stage) and at E8-8.5 (as the paired heart tubes form and fuse). Expression patterns for representative [21.5/10.8]GATA-6/lacZ and [1.5/10.0]GATA-6/lacZ transgenic mice are shown in Fig. 2A ,C,E and B,D,F, respectively. The images shown in Fig. 2A ,B reveal that this enhancer is preferentially active in the posterior region of the heart field as early as E7.5. Note that only two other enhancers have previously been shown to function in a heart-region-specific manner prior to linear heart tube formation (Ross et al., 1996; Xavier-Neto et al., 1999) .
In slightly older (E7.5-8) embryos it becomes increasingly evident that the [21.5/10.8]cGATA-6/lacZ and [1.5/10.0]cGATA-6/lacZ constructs are also differentially expressed along the medial/lateral (M/L) axis of the heart field. Sections through the left half of the cardiac crescent in the embryo from Fig. 2D are shown in Fig. 2G ,H, as indicated, to illustrate this point. Shown for comparison in the upper right (control) panel is a section through an embryo from a previously described transgenic line in which lacZ is expressed throughout the early heart field under the control of an early-heart-specific enhancer (Davis et al., 2000) . The double white arrows in these panels bracket the cardiogenic regions while the black arrows in Fig. 2G ,H point to subsets of cells that express the cGATA-6/lacZ transgene. These results provide the first evidence that myocardial cells are assigned positional information along the M/L axis as early as the cardiac crescent stage. Note that transgene expression at this stage appears to shift more toward the lateral margin as one moves in a more posterior direction (compare Fig. 2G and H).
The enhancer continues to function in a heart-regionspecific manner as the two heart primordia begin to pair ( Fig. 2I is particularly striking as it reveals that expression is restricted to the lateral sides of the two paired heart tubes that will become the lateral sides of the single (fused) linear heart tube. As the heart tube loops to the right and twists with a clockwise rotation over the next 2 days of development, these lateral (left and right) bands of expression become somewhat more refined and come to lie on the top and bottom, respectively of the AV canal ( Fig. 1 ; also data not shown).
Immunohistochemical studies suggest that the right margin of the AV canal gives rise to the AVCS during human heart development . However, this inference remains to be confirmed by lineage tracing in a tractable animal model. Since a comparable portion of the AV canal lies within the region marked by GATA-6/lacZ expression prior to AVCS morphogenesis in the mouse (see Fig. 1 ), it was of interest to determine if this enhancer remains active in the mouse AVCS. To address this issue we examined transgene expression in somewhat older embryos that have undergone AVCS morphogenesis. As shown in Fig. 3 , a superficial examination of a truncal section of an embryo (Fig. 3A) or an isolated heart (Fig. 3B ) reveals that transgene expression is confined to the developing AVCS by E14. In the isolated heart, robust expression is seen in the AV node (blue arrow), right AV ring (white arrow) whereas some weak expression still persists in the left AV junction (red arrow) at this stage. These expression domains are confirmed by the series of histological sections shown in Fig. 3C -I, which also reveal expression in the AV bundle (black arrow).
Retinoic acid perturbs transgene expression along the A/P axis
Several lines of evidence indicate that retinoic acid (RA) patterns the A/P axis of the early heart field. For example, Rosenthal and colleagues showed that if mouse embryos are treated with exogenous RA between E7.5 and E8.5, the posterior zone of atrial (and AV) cell specification expands at the expense of the anterior zone of ventricular cell specification (Xavier-Neto et al., 1999) . They also noted that elevated levels of RA rather generally retard embryonic development and, more specifically, often stunt the anterior pole of the heart, resulting in the formation of a closed rather than an open heart tube. To confirm that RA can modulate the expression of another marker along the A/P axis of the murine heart field, and to test if RA can also pattern the M/L axis of the heart field, we treated cGATA-6/lacZ embryos in utero with exogenous RA at E7.5 and then assayed transgene expression at E8.5 or E9.5. The results of this analysis are presented in Fig. 4 , with control and RA-treated embryos shown in Fig. 4A ,B and C,D, respectively. As expected for an AV myocardial cell marker, RA caused the expression of this transgene to expand essentially all the way to the anterior pole of the stunted heart tube at E8.5 and E9.5 (compare Fig.  4C ,D with A,B, respectively). In contrast, this treatment did not obviously perturb the strong M/L bias in transgene expression (see Fig. 4C,D) . As summarized in cartoon fashion in Fig. 4 , we infer that distinct mechanisms are used to pattern the A/P and M/L axes of the heart field.
2.3. Generation of cGATA-6/Cre transgenic mice that selectively delete floxed genes in the developing AVCS As documented in the preceding sections, cGATA-6/lacZ transgenes highlight several sequential facets of heart development. In principle, this same cGATA-6 gene fragment , (E,F), respectively). The posterior portions of left and right heart forming regions in (A) and (B), respectively, lie within the boxed regions. Sections through embryos from (D) and (F) are shown in (G) and (H) and panels (I-K) as indicated. The image in the upper right corner (denoted control) is from an unrelated transgenic line that expresses bgalactosidase in essentially all cardiogenic cells at this stage (Davis et al., 2000) . The approximate limits of the left heart-forming regions in the control panel, as well as in (G) and (H), are indicated by double white arrows. The black arrows in (G-K) point to subsets of cardiogenic cells in which the cGATA-6 proximal enhancer is active. aip, anterior intestinal portal; cc. cardiac crescent; ht, heart tube; nt, neural tube.
could also be used to express functional (as opposed to reporter) transgenes in the respective subsets of specialized heart cells. As a case in point, we undertook to make cGATA-6/Cre mice that could be used in combination with mice with floxed genes to target gene deletions to a discrete segment of the cardiac conduction system.
We made two lines of transgenic mice with a [21.5/ 10.0]cGATA-6/Cre construct and mated these to ROSA26 Cre reporter (R26R) mice in order to monitor the cumulative (clonal) history of Cre activity at different stages of development. R26R mice constitutively express a defective (floxed) lacZ gene that can be 'corrected' in a Cre mediated fashion (Soriano, 1999) . Once this occurs, the resultant functional lacZ gene continues to mark all of the clonal cellular derivatives. For matings between cGATA-6/ Cre and R26R mice, we thus expected to see lacZ expression in the mature AVCS as well as in cells (or the derivatives thereof) that transiently activate the cGATA-6 gene enhancer early in development but are not subsequently incorporated into the mature AVCS. Indeed, this prediction was borne out by the results shown in Fig. 5 (also data not shown). In particular, sections through Cre x R26R, doubly transgenic, neonate hearts (such as the one shown in Fig.  5A ) clearly confirm that the AV node and AV bundle are blue (Fig. 5B,C) . Note also that the left ventricle is marked by patches of blue cells which fall into two roughly parallel tracks, one of which is largely obscured on the left side of Fig. 5A (but see Fig. 5H below) . These marked ventricular cells are not components of the distal conduction system and, so far as we are aware, do not correspond to any other previously described subset of specialized ventricular cells. The neonate atria also contain some blue cells.
The salient features of the ventricular and AV aspects of this Cre x R26R expression pattern are evident in E8.5 and E9.5 hearts (Fig. 5D ,E, respectively) while the atrial aspect is evident by E12.5 (Fig. 5F-H) . Recall that cGATA-6 gene enhancer activity is restricted to two lateral regions of cardiogenic cells even prior to formation of the linear heart tube (see Fig. 2 ) and that it is inactivated in prospective ventricular cells prior to E9.5 (see Fig. 1 ). Thus, in addition to providing a means to delete floxed genes in the AVCS, and not in other components of the conduction system, cGATA-6/Cre mice can be used to monitor the fates of particular subsets of early heart cells. A more detailed fate map analysis of these cells will be presented elsewhere.
The GATA-6 enhancer contains essential and important elements
The 1.5 kb DNA fragment that drives the aforementioned transgene expression patterns must contain binding sites for a particular combination of active transcription factors that, in the mature heart, is restricted to the AVCS. Whereas this set likely includes some well characterized heart-restricted factors, none of these factors are known to be restricted to the AVCS or to the subsets of heart cells that are marked by these transgenes earlier in development, prior to AVCS formation. Since this set of factors might also be expected to regulate biologically relevant, AVCS specific, genes, it is of interest to resolve how this prototypical enhancer is regulated at the molecular level.
Having determined that sequences in the cGATA-6 gene first intron are not required to direct heart-region-specific expression (see Fig. 1 ), we proceeded to assay the effects of deleting sequences from either end of the parental [21.5/ 0.0] fragment. As summarized in Fig. 6 , removal of the Fig. 4 . Retinoic acid modulation of cGATA-6/lacZ transgene expression. Embryos were treated on E7.5 with inert sunflower oil alone (A,B) or sunflower oil plus retinoic acid (C,D) and then assayed for lacZ expression on E8.5 (A,C) or E9.5 (B,D), as indicated. Mock-treated embryos preferentially expressed the transgene on the two lateral sides of the AV canal but not on the two medial sides (as indicated by the arrow heads and double-headed arrows, respectively). In the retinoic acid treated embryos, transgene expression extended toward the (stunted) anterior pole of the heart but remained laterally restricted. As indicated in cartoons on the left, we infer that the lateral aspect of the early heart field is specified in a retinoic acid independent manner (indicated by the zone of horizontal hatching) while the posterior heart field is specified in a retinoic acid dependent manner (indicated by the zone of diagonal hatching). distal [21.5/21.2] region precluded heart-specific expression in all 19 of the transient transgenic mouse embryos assayed. We therefore conclude that this distal region contains one or more essential positive control elements. To test whether these positive control elements might function to overcome more proximal negative control elements, we assayed two constructs that include the cGATA-6 gene promoter and either 0.9 or 0.3 kb of flanking sequences. As summarized in Fig. 6 , these constructs were both inactive in E9.5 transient transgenic mouse embryos. To test whether the [21.5/21.2] region might not only be necessary but also sufficient to direct heart-region-specific expression, we inserted this fragment upstream of a heterologous promoter in the hsp68/lacZ vector (Kothary et al., 1989) and assayed the resultant test construct in E9.5 transient transgenic embryos. As summarized in Fig. 6 , this fragment failed to direct expression in all nine transgenic embryos assayed. However, the inclusion of an additional 0.3 kb (i.e. the [21.5/20.9] fragment) allowed a majority of the resultant transgenic embryos to display some degree of heart-region-specific expression (for example, see Fig.  6C ). The [21.5/20.3] cGATA-6 gene fragment, which is twice as large, directed an expression pattern that was perhaps somewhat more refined (for example, see Fig.  6A,B) . However, the expression patterns seen with this .0] region to provide a framework for future efforts to resolve the individual elements that comprise this heart-region-specific enhancer (see Fig. 7) . A superficial inspection of the essential [21.5/21.2] sequence revealed an Nkx2.5 site at position 21242 (which was confirmed by gel shift analysis; data not shown). However, a site-directed mutational analysis further revealed that this Nkx2.5 site (which is highlighted in green in Fig. 7) is not required for heart-region-specific expression in E9.5 transient transgenic embryos (data not shown). This [21.5/21.2] sequence also contains four GATA sites (Fig. 7 , highlighted in blue) that each deviate from the WGATAR consensus at the first position and therefore are predicted to be relatively low-affinity binding sites for GATA-4/5/6. It may also be significant that this distal region has numerous sequence motifs (Fig. 7 , highlighted in red) that resemble one class of consensus SMAD sites (Kusanagi et al., 2000) . Future studies will be directed at testing if these GATA and SMAD sites are functionally relevant. On the other hand, this critical [21.5/21.2] region lacks E-box bHLH sites and obvious consensus sites for the heart restricted MEF-2 or SRF factors. This region is also devoid of consensus retinoic acid response elements. Lastly, as indicated in Fig. 7 , the parental [21.5/0.0] region contains two blocks of sequence that are also conserved in the mouse and human GATA-6 genes. These conserved blocks map to regions upstream of the cGATA-6 gene that may be important, but are neither necessary nor sufficient, to direct the heart-region-specific transgene expression described in the present report. In accord with this result, a fragment that includes these conserved blocks from the mouse GATA-6 gene was also found to be insufficient to direct heart-specific expression (Molkentin et al., 2000) .
Discussion
One of the most intriguing questions in cardiac morphogenesis is how a simple embryonic heart tube develops into a complex multichambered heart that supports two serially connected (systemic and pulmonary) circulations. Crucial morphogenetic events in this process include the formation of septa, which separate the left atrial and ventricular components from their right counterparts (e.g. Wessels et al., 2000) , and the development of valves (e.g. Wessels et al., 1996) which prevent the backflow of blood during diastole. In addition, an electrophysiologic conduction system is formed to enable the heart to function as an efficient unidirectional pump. In all these events the tissues of the AV canal play critical roles. Our present analysis of a cGATA-6 gene enhancer provides insights into the origin of the AV conduction system (AVCS) and the transcriptional programs that govern these cells and the AV myocardial cells that orchestrate the formation of AV septa and AV valves.
The Origin of the AVCS
In the early embryonic heart the AV canal functions to delay the cardiac impulse from the atria to the ventricles. During development most of the atrial and ventricular myocardium becomes physically separated by the fibrous annulus, which is formed by the fusion of endocardial cushion derived mesenchyme and epicardially derived sulcus tissue (Wessels et al., 1996) . The only myocardial connection that remains is through the proximal part of the AVCS, the properties of which delay the (sinoatrial node generated) cardiac impulse as noted above. Without a proper delay at the AV canal, the ventricles contract too early in the cardiac cycle, a phenomenon known as ventricular pre-excitation.
An increasing body of evidence indicates that the AVCS develops, at least in part, from the myocardium of the AV canal. Interestingly, the AV canal in the embryonic heart tube functions in a manner similar to the AV node in the multichambered heart. This is indicated by the fact that the tubular heart already shows an electrocardiogram with a characteristic delay of the cardiac impulse in the AV canal myocardium (Arguello et al., 1986; de Jong et al., 1992) . Similarly, the molecular phenotype of AV canal myocardium remains relatively stable as development proceeds and resembles that seen in the mature AV node. It has been suggested that the primary heart tube consists of so-called primary myocardium, which is characterized by a gene expression profile that persists in the developing AV conduction system but is gradually lost in the flanking atrial and ventricular segments (reviewed in (Moorman et al., 1998; Moorman and Lamers, 1999) ).
It is not known how these expression patterns are governed. It is thus significant that we have identified an enhancer that is differentially regulated in this precise developmental context. Whereas minK gene lacZ knock-in mice (Kupershmidt et al., 1999 ) and a singular engrailed-2/lacZ transgenic line (Rentschler et al., 2001 ) mark one or more components of the conduction system, the enhancers that dictate the respective expression patterns remain to be identified. This cGATA-6 enhancer is also unique in that it drives AV canal specific expression at very early stages of heart tube formation. Our results suggest that AVCS tissue may not differentiate from a common myocardial cell at a relatively late stage of development (see Cheng et al., 1999) but rather may be predisposed to this specialized cell fate at the outset of the cardiogenic program.
Formation of the definitive AV conduction system
Previous studies have indicated that only a part of the AV canal myocardium ultimately contributes to the definitive Fig. 7 . Sequence of the cGATA-6 gene flanking region that directs heart-region-specific expression in transgenic mice. The [21.5/0.0] fragment is numbered relative to the previously mapped (He and Burch, 1997) transcriptional start site, the underlined G residue at position 11. Restriction sites that were used to delineate critical and important regions (see Fig. 6 ) are highlighted in yellow. Shown also are two blocks of sequence homology from the mouse (mm) and human (hs) GATA-6 genes (denoted c1 and c2 in Fig. 6 ). In mouse and human, these conserved blocks are spaced 1.1 and 1.0 kb apart, respectively, as indicated.
AVCS . In particular, immunohistochemical studies in human showed that the AVCS develops from those myocardial cells that are shared between the (right margin of) the AV canal and the so-called primary ring that encircles the primary ventricular foramen Wessels et al., 1992) . Interestingly, the sustained expression of cGATA-6 transgenes in the right portion of the AV canal (which develops into the right AV ring, AV node and AV bundle) appears to provide a molecular read-out of these critical phenotypic events. In contrast, the band of cGATA-6 transgene expression that initially encircles the left portion of the AV canal gradually fades away following induction of the left endocardial cushion. A detailed spatiotemporal description of this process will be presented in a forthcoming paper.
Development of the endocardial cushions of the AV canal
Another critical, but poorly understood, aspect of the development of the AV canal relates to the initial formation of the endocardial cushions that give rise to the mitral and tricuspid valves. Although much work has focused on conserved molecular and cellular mechanisms that induce endocardially-derived mesenchymal cells to migrate into these cushions, as well as into the endocardial cushions that form in the outflow tract, several other fundamental questions have received little attention. For example, it is not known whether AV canal and OT myocardial cells impart distinct positional cues to the respective underlying AV canal and OT endocardial cells to instruct them to form distinct valvular structures. It is also not known why only two (contralateral) cushions initially develop in the AV canal or what determines where in the AV canal these cushions develop. With respect to the latter question, it is interesting to note that cGATA-6 transgene expression is restricted to two opposite sides of AV canal myocardium that lie over, and induce the formation of, the two major AV cushions. We suggest that the combination of transcription factors that regulates this cGATA-6 transgene might also regulate endogenous genes that are differentially expressed in these AV myocardial cells as part of the program that specifically regulates AV valvulogenesis (as opposed to OT valvulogenesis). Furthermore, our results indicate that the transcriptional program that specifies where the AV cushions form may also subsequently be used to elaborate the AVCS in proper spatial relationship to the valves that develop at these sites. We showed that the 1.5 kb cGATA-6 flanking sequence can read this unique transcriptional milieu with high fidelity. Of relevance to both of the above questions, our results suggest that the roots of this laterally restricted pattern can be traced all the way back to the outset of the cardiogenic program.
It is tempting to speculate that SMAD factors may play a key role in defining this unique transcriptional milieu. BMP-2, which activates SMAD factors, is expressed in proximity to, or coincident with, myocardial cells that express cGATA-6/lacZ transgenes early in the cardiogenic program and at the time of endocardial cushion formation (Lyons et al., 1990; Schultheiss et al., 1997; Yamada et al., 2000) ; it remains to be determined if BMP-2 continues to be expressed in the mature AVCS. On the other hand BMP antagonists, which are expressed in early axial structures, might reduce SMAD activity in the medial heart field below a threshold required to activate this enhancer. A potential role for BMP-2 is also supported by our finding that the critical region of the cGATA-6 gene enhancer contains a plethora of potential SMAD binding sites. Future studies will be directed at testing whether these SMAD sites are functionally relevant.
Modular transcriptional regulation in the developing heart
As noted in the introduction, the evolutionarily conserved cGATA-6 gene is an early and persistent marker of the cardiogenic lineage. Thus far we have identified two enhancers upstream of the cGATA-6 gene that direct (spatially and temporally) distinct facets of heart-specific expression in transgenic mice. As detailed above, one enhancer functions in a heart-region-specific manner from very early stages of heart development and continues to function in the mature AVCS. The other enhancer, which is located 6 kb upstream of the gene (Davis et al., 2000) , is also activated early in the cardiogenic program. However, in contrast to the enhancer that is the subject of this report, the more distal enhancer initially functions in essentially all cardiogenic cells (see control panel in Fig. 2) . Furthermore, the more distal enhancer is inactivated as development proceeds beyond the heart looping stage, except in a narrow band of outflow tract myocardium (Davis et al., 2000) . These observations suggest that the heart-specific expression of the endogenous gene may be effected in a modular manner. Furthermore, since these enhancers do not fully recapitulate the pattern of endogenous cGATA-6 gene expression, we suspect that this gene may be flanked by additional heart-specific enhancers. The mouse GATA-6 gene (Molkentin et al., 2000) as well as other genes that are expressed early in the cardiogenic lineage such as the chicken GATA-5 gene (MacNeill et al., 2000) , the mouse Nkx2.5 transcription factor gene (Lien et al., 1999; Reecy et al., 1999; Schwartz and Olson, 1999; Searcy et al., 1998; Tanaka et al., 1999) and the mouse cardiac-restricted ankyrin repeat (CARP) gene (Kuo et al., 1999) are also flanked by multiple enhancers that function in different subsets of myocardial cells or at different stages of heart development. Modular regulation appears to be the rule rather than the exception during heart development.
The limited number of (early and late) cardiac gene enhancers that have been identified thus far have already revealed a remarkable degree of transcriptional complexity in the developing heart (reviewed in Kelly et al., 1999; Schwartz and Olson, 1999) . In addition, many of these enhancers provide suggestive evidence of possible lineage relationships in the developing heart, as assayed using direct read-out transgene reporter systems such as the b galactosidase (lacZ) gene. In the present study we obtained definitive evidence of particular lineage relationships within the developing mouse heart by mating cGATA-6/Cre 'cardioeffector' mice with ROSA26 Cre reporter mice (Soriano, 1999) . For example, this analysis confirmed that the two lateral bands of enhancer activity seen early in the cardiogenic program span prospective left ventricle, AV and atrial regions. These cGATA-6/Cre mice can also be used to delete (floxed) genes that are normally expressed in the developing conduction system. This should be particularly valuable in cases where gene deletions cause early embryonic lethality or alter (either directly or indirectly) the properties of multiple components of the conduction system, as in the case of the HF-1b gene (Nguyen-Tran et al., 2000) . Similarly, by expressing fluorescent proteins under the control of these enhancers it should be possible to isolate and characterize particular precursor cell populations at specific stages of heart development. Lastly, these enhancers could be used to express functionally relevant genes (or mutated versions thereof) in particular cells of the developing heart. These molecular reagents should therefore prove to be of significant value in the development and analysis of mouse models for various congenital heart defects of relevance to human health.
Materials and methods

Transgenic constructs
The [21.5/10.8]cGATA-6/lacZ construct was described in a previous publication (He and Burch, 1997) . This 2.3 kb cGATA-6 gene fragment was also cloned upstream of the (nuclear localization signal tagged) Cre gene in the plasmid pMC-Cre ( (Gu et al., 1993) ) to generate the [21.5/ 10.8]cGATA-6/Cre construct. The [21.5/10.0]cGATA-6/lacZ construct was made by cloning the 1.5 kb SacI to BamHI fragment (with SalI linkers on the SacI end) into pPD46.21.NotI (He and Burch, 1997) . Note that the BamHI site maps 19 bp downstream of the major transcriptional start site for the cGATA-6 gene (He and Burch, 1997 ; see also Fig. 7) . Similar strategies were used to clone the 1.2 kb (Bsu36AI to BamHI), 0.9 kb (SmaI to BamHI) and 0.3 kb (FspI to BamHI) fragments into pPD46.21.NotI. These restriction sites were used to clone the [21.5/20.3], [21.5/20.9] and [21.5/21 .2] fragments into the SmaI site of pHSP68/lacZ (Kothary et al., 1989) .
Production and analysis of transgenic mouse embryos
Fragments were isolated from the pPD46.21.NotI and pHSP68/lacZ plasmids using NotI alone or a combination of HindIII and SalI, respectively. The cGATA-6/Cre fragment was isolated using SalI. These fragments were microinjected into fertilized oocyte pronuclei, eggs were transferred into the oviducts of pseudopregnant females and transgenic embryos and mice were identified by a polymerase chain reaction analysis of embryo DNA and tail DNA, respectively (Hogan et al., 1994) . Note that embryos were staged using the criteria of (Kaufman, 1995) and genotyped after being assayed for lacZ activity using standard protocols (Hogan et al., 1994) . In the case of the cGATA-6/ Cre lines, transgenic mice were mated to ROSA26 reporter (R26R) mice in order to convert (transient or persistent) Cre activity into (stable and heritable) lacZ activity in the resultant double transgenic embryos (Soriano, 1999) . Embryos were treated with exogenous retinoic acid as described by Rosenthal and colleagues (Xavier-Neto et al., 1999) . Representative stained specimens were embedded in paraffin and serially sectioned at 5 mm. Selected sections were either counterstained with nuclear fast red or immunohistochemically stained for the presence of smooth muscle actin (Sigma, A2547) as described previously (Huang et al., 1998) . Images of the counterstained sections were digitally recorded using a Polaroid DMC camera mounted on a Olympus BX40 microscope. Using these images threedimensional reconstructions of selected specimens were generated using 3D-DOCTOR software (Able Software Corp.) on a personal computer.
